Predicted protein targets (top 11)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CCR5 | P51681 | 12/20 | 0.41 |
| ▸ | DGAT2 | Q96PD7 | 1/20 | 0.37 |
| ▸ | UTS2R | Q9UKP6 | 2/20 | 0.35 |
| ▸ | HPGD | P15428 | 1/20 | 0.35 |
| ▸ | KCNK3 | O14649 | 1/20 | 0.35 |
| ▸ | LMNA | P02545 | 1/20 | 0.35 |
| ▸ | GAA | P10253 | 1/20 | 0.35 |
| ▸ | PKM | P14618 | 1/20 | 0.35 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.35 |
| ▸ | SIGMAR1 | Q99720 | 1/20 | 0.34 |
| ▸ | CTSL | P07711 | 1/20 | 0.34 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL4693400 | 0.95 | CCR5 (0.41) | CCR5DGAT2UTS2RKCNK3LMNA | |
| SCHEMBL4692747 | 0.93 | CCR5 (0.44) | CCR5UTS2RLMNAKMT2ASIGMAR1 | |
| SCHEMBL4694396 | 0.91 | CCR5 (0.44) | CCR5UTS2RSIGMAR1 | |
| SCHEMBL4691249 | 0.91 | CCR5 (0.44) | CCR5DGAT2UTS2RKMT2A | |
| SCHEMBL4690226 | 0.90 | CCR5 (0.46) | CCR5UTS2RSIGMAR1 | |
| SCHEMBL4694765 | 0.90 | CCR5 (0.44) | CCR5DGAT2UTS2R | |
| SCHEMBL4690242 | 0.90 | CCR5 (0.43) | CCR5DGAT2UTS2RSIGMAR1 | |
| SCHEMBL4690858 | 0.89 | CCR5 (0.48) | CCR5DGAT2UTS2RSIGMAR1 | |
| SCHEMBL4694157 | 0.88 | CCR5 (0.46) | CCR5UTS2RLMNAKMT2A | |
| SCHEMBL4693825 | 0.88 | CCR5 (0.41) | CCR5UTS2RHPGDKMT2A |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-1761542-B1 | OCTAHYDROPYRROLO[3,4-C]PYRROLE DERIVATIVES AN THEIR USE AS ANTIVIRAL AGENTS | HOFFMANN LA ROCHE (CH) | 2008-01-02 | — | — | EP | claimed |